查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1513322

蛋白质体学市场：按组成部分、按应用划分：2024-2035 年全球机会分析和产业预测

Proteomics Market By Component (Reagents, Instruments, Services), By Application (Drug Discovery, Disease Diagnosis, Others): Global Opportunity Analysis and Industry Forecast, 2024-2035
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3个工作天内

价格
2023年全球蛋白质体市场价值为328亿美元，预计到2035年将达到1,619亿美元，2024年至2035年复合年增长率为14.2%。蛋白质体学是分子生物学的一个分支，重点在于蛋白质及其结构、功能和生物系统内的相互作用。与研究生物体内整个基因组的基因体学不同，蛋白质体学专门针对蛋白质体。蛋白质组是指由细胞、组织和生物体所表达的一组蛋白质。蛋白质体学领域包括旨在了解蛋白质在生物过程中的作用和行为的各种技术和方法，例如蛋白质表现谱、蛋白质-蛋白质相互作用、转译后修饰和蛋白质定位。
蛋白质体学市场-IMG1
蛋白质体学市场的成长归因于蛋白质体学在疾病诊断中的高采用率、技术进步以及生命科学研究的不断增加。蛋白质体学是对蛋白质的大规模研究，可以全面了解生物系统中蛋白质之间的动态相互作用，并揭示疾病的发病机制和进展。根据国家医学图书馆2021年发表的一篇论文，癌症蛋白质组学阐明了肿瘤生长和转移机制研究中的重要信息，并为临床适用的生物标誌物和治疗靶点的识别做出了贡献。随着质谱和蛋白质微阵列技术等技术的进步，蛋白质体学使研究人员和临床医生能够以前所未有的准确性和灵敏度识别指示特定疾病的生物标记。蛋白质体学市场正在经历显着的快速成长，这主要是由于对生命科学领域研究的日益关注所推动。随着科学认识的加深和技术进步的加速，对蛋白质体学解决方案的需求呈指数级增长。蛋白质体学是对生物系统中蛋白质及其功能的研究，在阐明复杂的细胞机制、疾病途径和药物交互作用方面发挥着至关重要的作用。随着生命科学研究扩展到基因组学、转录组学和代谢体学等不同领域，蛋白质体学已成为一种补充工具，为生物系统的复杂运作提供重要见解。例如，国家医学图书馆 2021 年的一份报告称，蛋白质体学已成为分子科学的一个重要领域，因为它提供了有关蛋白质身份、表达水平和修饰的宝贵资讯。此外，个人化医疗的兴起和对标靶治疗的探索正在推动对精确蛋白质分析技术的需求。这推动了对质谱、蛋白质微阵列和生物资讯解决方案等蛋白质组学技术的投资，以开发更准确的诊断工具和治疗性介入。蛋白质体学市场按成分、应用和区域进行细分。依组成部分，市场分为试剂、设备和服务。按应用划分，市场分为药物发现、疾病诊断等。按地区划分，北美（美国、加拿大、墨西哥）、欧洲（德国、法国、英国、义大利、西班牙、其他欧洲国家地区）、亚太地区（日本、中国、澳洲、印度、韩国、其他亚太地区） ）、欧洲（巴西、哥伦比亚、阿根廷、亚太其他地区）、中东和非洲（海湾合作委员会、南非、北非、中东和非洲其他地区）。蛋白质体学市场的主要企业主要企业有 Bio-Rad Laboratories Inc.、Danaher Corporation、Bruker Corporation、Waters Corporation、Perkin Elmer Inc.、Horiba、Merck KGaA、Agilent Technologies Inc.、Li-Cor Inc.。发布作为关键发展策略，以改善蛋白质体学市场的产品系列。
  • 本报告定量分析了 2023 年至 2035 年蛋白质组学市场分析的细分市场、当前趋势、估计/趋势和动态，并确定了蛋白质组学市场的强大机会。
  • 我们提供市场研究以及与市场驱动因素、市场限制和市场机会相关的资讯。
  • 波特的五力分析揭示了买家和供应商的潜力，帮助相关人员做出利润驱动的业务决策并加强供应商和买家网路。
  • 蛋白质体学市场细分的详细分析有助于识别市场机会。
  • 每个地区的主要国家都根据其对全球市场的收益贡献绘製了地图。
  • 市场参与者定位有助于基准化分析，并提供对市场参与者当前地位的清晰了解。
  • 该报告包括对区域和全球蛋白质组市场趋势、主要企业、细分市场、应用领域和市场成长策略的分析。

目录

第一章简介

第 2 章执行摘要

第三章市场概况

  • 市场定义和范围
  • 主要发现
    • 影响因素
    • 主要投资机会
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章蛋白质体学市场：依组成部分

  • 概述
  • 试剂
    • 试剂蛋白质体学市场：按试剂类型
  • 装置
    • 仪器蛋白质体学市场：依仪器类型
  • 服务

第五章蛋白质体学市场：依应用分类

  • 概述
  • 药物发现
  • 疾病诊断
  • 其他的

第六章蛋白质体学市场：按地区

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 拉丁美洲/中东/非洲
    • 巴西
    • 沙乌地阿拉伯
    • 南非
    • 其他的

第七章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 2023年主要企业定位

第八章 公司简介

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Waters Corporation
  • Bio-Rad Laboratories Inc
  • Agilent Technologies Inc.
  • Li-Cor Inc
  • Bruker Corporation
  • Perkin Elmer Inc
  • Danaher Corporation
  • Horiba Ltd.
Product Code: A01352
The global proteomics market was valued at $32.8 billion in 2023 and is projected to reach $161.9 billion by 2035, growing at a CAGR of 14.2% from 2024 to 2035. Proteomics is a branch of molecular biology that focuses on the study of proteins, their structures, functions, and interactions within a biological system. Unlike genomics, which deals with the study of an organism's entire genome, proteomics specifically targets the proteome, which refers to the complete set of proteins expressed by a cell, tissue, or organism. The field of proteomics encompasses various techniques and methodologies aimed at understanding the roles and behaviors of proteins in biological processes, including protein expression profiling, protein-protein interactions, post-translational modifications, and protein localization.
Proteomics Market - IMG1
The proteomics market growth is attributed to high adoption of proteomics in disease diagnosis, technological advancements, and increase in research in life sciences. Proteomics, the large-scale study of proteins, offers a comprehensive understanding of the dynamic interplay between proteins within biological systems, shedding light on disease pathogenesis and progression. According to a 2021 article by National Library of Medicine, it was reported that cancer proteomics unraveled key information in mechanistic studies on tumor growth and metastasis, which has contributed to the identification of clinically applicable biomarkers as well as therapeutic targets. With advancements in technology, such as mass spectrometry and protein microarray techniques, proteomics enables researchers and clinicians to identify biomarkers indicative of specific diseases with unprecedented accuracy and sensitivity. Thus, the increasing adoption of proteomics in disease diagnosis is expected to drive growth of proteomics industry.The proteomics market is experiencing a significant surge, largely driven by the increasing emphasis on research in the life sciences sector. As scientific understanding deepens and technological advancements accelerate, the demand for proteomics solutions has grown exponentially. Proteomics, the study of proteins and their functions within biological systems, plays a pivotal role in elucidating complex cellular mechanisms, disease pathways, and drug interactions. With life sciences research expanding across various disciplines such as genomics, transcriptomics, and metabolomics, proteomics has emerged as a complementary tool offering crucial insights into the intricate workings of biological systems. For instance, according to 2021 report by National Library of Medicine, it was reported that proteomics has become an important field in molecular sciences, as it provides valuable information on the identity, expression levels, and modification of proteins. Moreover, the rise of personalized medicine and the quest for targeted therapies have fueled the need for precise protein analysis techniques. This has propelled investments in proteomics technologies, including mass spectrometry, protein microarrays, and bioinformatics solutions, to develop more accurate diagnostic tools and therapeutic interventions. Thus, the rise in research in the life sciences sector is expected to drive the growth of the market.The proteomics market is segmented on the basis of component, application, and region. By component, the market is divided into reagents, instruments and services. By application, the market is divided into drug discovery, diseases diagnosis, and other. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), LA (Brazil, Colombia, Argentina, and rest of LA), and MEA (GCC, South Africa, North Africa, and rest of MEA).Major key players that operate in the proteomics market are Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc., Danaher Corporation, Bruker Corporation, Waters Corporation, Perkin Elmer Inc, Horiba Ltd., Merck KGaA, Agilent Technologies Inc., Li-Cor Inc. Key players have adopted collaboration, and product launch as a key developmental strategy to improve the product portfolio of the proteomics market.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the proteomics market analysis from 2023 to 2035 to identify the prevailing proteomics market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the proteomics market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global proteomics market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Component

  • Reagents
    • Reagents Type
    • Microarray
    • X Ray Crystallography
    • Spectrometry
    • Chromatography
    • Electrophoresis
    • Immunoassay
    • Protein Fractionation Reagents
  • Instruments
    • Instruments Type
    • Microarray
    • Spectrometry
    • Chromatography
    • Electrophoresis
    • Surface Plasmon Resonace
    • X Ray Crystallography
    • Protein Fractionation Reagents
  • Services

By Application

  • Drug Discovery
  • Disease Diagnosis
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Waters Corporation
    • Bio-Rad Laboratories Inc
    • Agilent Technologies Inc.
    • Li-Cor Inc
    • Bruker Corporation
    • Perkin Elmer Inc
    • Danaher Corporation
    • Horiba Ltd.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: PROTEOMICS MARKET, BY COMPONENT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Reagents
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
    • 4.2.4. Reagents Proteomics Market by Reagents Type
  • 4.3. Instruments
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
    • 4.3.4. Instruments Proteomics Market by Instruments Type
  • 4.4. Services
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: PROTEOMICS MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Drug Discovery
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Disease Diagnosis
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: PROTEOMICS MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by Component
    • 6.2.3. Market size and forecast, by Application
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Market size and forecast, by Component
      • 6.2.4.1.2. Market size and forecast, by Application
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Market size and forecast, by Component
      • 6.2.4.2.2. Market size and forecast, by Application
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Market size and forecast, by Component
      • 6.2.4.3.2. Market size and forecast, by Application
  • 6.3. Europe
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by Component
    • 6.3.3. Market size and forecast, by Application
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. Germany
      • 6.3.4.1.1. Market size and forecast, by Component
      • 6.3.4.1.2. Market size and forecast, by Application
      • 6.3.4.2. France
      • 6.3.4.2.1. Market size and forecast, by Component
      • 6.3.4.2.2. Market size and forecast, by Application
      • 6.3.4.3. UK
      • 6.3.4.3.1. Market size and forecast, by Component
      • 6.3.4.3.2. Market size and forecast, by Application
      • 6.3.4.4. Italy
      • 6.3.4.4.1. Market size and forecast, by Component
      • 6.3.4.4.2. Market size and forecast, by Application
      • 6.3.4.5. Spain
      • 6.3.4.5.1. Market size and forecast, by Component
      • 6.3.4.5.2. Market size and forecast, by Application
      • 6.3.4.6. Rest of Europe
      • 6.3.4.6.1. Market size and forecast, by Component
      • 6.3.4.6.2. Market size and forecast, by Application
  • 6.4. Asia-Pacific
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by Component
    • 6.4.3. Market size and forecast, by Application
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. Japan
      • 6.4.4.1.1. Market size and forecast, by Component
      • 6.4.4.1.2. Market size and forecast, by Application
      • 6.4.4.2. China
      • 6.4.4.2.1. Market size and forecast, by Component
      • 6.4.4.2.2. Market size and forecast, by Application
      • 6.4.4.3. India
      • 6.4.4.3.1. Market size and forecast, by Component
      • 6.4.4.3.2. Market size and forecast, by Application
      • 6.4.4.4. Australia
      • 6.4.4.4.1. Market size and forecast, by Component
      • 6.4.4.4.2. Market size and forecast, by Application
      • 6.4.4.5. South Korea
      • 6.4.4.5.1. Market size and forecast, by Component
      • 6.4.4.5.2. Market size and forecast, by Application
      • 6.4.4.6. Rest of Asia-Pacific
      • 6.4.4.6.1. Market size and forecast, by Component
      • 6.4.4.6.2. Market size and forecast, by Application
  • 6.5. LAMEA
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by Component
    • 6.5.3. Market size and forecast, by Application
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Brazil
      • 6.5.4.1.1. Market size and forecast, by Component
      • 6.5.4.1.2. Market size and forecast, by Application
      • 6.5.4.2. Saudi Arabia
      • 6.5.4.2.1. Market size and forecast, by Component
      • 6.5.4.2.2. Market size and forecast, by Application
      • 6.5.4.3. South Africa
      • 6.5.4.3.1. Market size and forecast, by Component
      • 6.5.4.3.2. Market size and forecast, by Application
      • 6.5.4.4. Rest of LAMEA
      • 6.5.4.4.1. Market size and forecast, by Component
      • 6.5.4.4.2. Market size and forecast, by Application

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product mapping of top 10 player
  • 7.4. Competitive dashboard
  • 7.5. Competitive heatmap
  • 7.6. Top player positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Thermo Fisher Scientific Inc.
    • 8.1.1. Company overview
    • 8.1.2. Key executives
    • 8.1.3. Company snapshot
    • 8.1.4. Operating business segments
    • 8.1.5. Product portfolio
    • 8.1.6. Business performance
    • 8.1.7. Key strategic moves and developments
  • 8.2. Merck KGaA
    • 8.2.1. Company overview
    • 8.2.2. Key executives
    • 8.2.3. Company snapshot
    • 8.2.4. Operating business segments
    • 8.2.5. Product portfolio
    • 8.2.6. Business performance
    • 8.2.7. Key strategic moves and developments
  • 8.3. Waters Corporation
    • 8.3.1. Company overview
    • 8.3.2. Key executives
    • 8.3.3. Company snapshot
    • 8.3.4. Operating business segments
    • 8.3.5. Product portfolio
    • 8.3.6. Business performance
    • 8.3.7. Key strategic moves and developments
  • 8.4. Bio-Rad Laboratories Inc
    • 8.4.1. Company overview
    • 8.4.2. Key executives
    • 8.4.3. Company snapshot
    • 8.4.4. Operating business segments
    • 8.4.5. Product portfolio
    • 8.4.6. Business performance
    • 8.4.7. Key strategic moves and developments
  • 8.5. Agilent Technologies Inc.
    • 8.5.1. Company overview
    • 8.5.2. Key executives
    • 8.5.3. Company snapshot
    • 8.5.4. Operating business segments
    • 8.5.5. Product portfolio
    • 8.5.6. Business performance
    • 8.5.7. Key strategic moves and developments
  • 8.6. Li-Cor Inc
    • 8.6.1. Company overview
    • 8.6.2. Key executives
    • 8.6.3. Company snapshot
    • 8.6.4. Operating business segments
    • 8.6.5. Product portfolio
    • 8.6.6. Business performance
    • 8.6.7. Key strategic moves and developments
  • 8.7. Bruker Corporation
    • 8.7.1. Company overview
    • 8.7.2. Key executives
    • 8.7.3. Company snapshot
    • 8.7.4. Operating business segments
    • 8.7.5. Product portfolio
    • 8.7.6. Business performance
    • 8.7.7. Key strategic moves and developments
  • 8.8. Perkin Elmer Inc
    • 8.8.1. Company overview
    • 8.8.2. Key executives
    • 8.8.3. Company snapshot
    • 8.8.4. Operating business segments
    • 8.8.5. Product portfolio
    • 8.8.6. Business performance
    • 8.8.7. Key strategic moves and developments
  • 8.9. Danaher Corporation
    • 8.9.1. Company overview
    • 8.9.2. Key executives
    • 8.9.3. Company snapshot
    • 8.9.4. Operating business segments
    • 8.9.5. Product portfolio
    • 8.9.6. Business performance
    • 8.9.7. Key strategic moves and developments
  • 8.10. Horiba Ltd.
    • 8.10.1. Company overview
    • 8.10.2. Key executives
    • 8.10.3. Company snapshot
    • 8.10.4. Operating business segments
    • 8.10.5. Product portfolio
    • 8.10.6. Business performance
    • 8.10.7. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 02. PROTEOMICS MARKET FOR REAGENTS, BY REGION, 2023-2035 ($MILLION)
  • TABLE 03. GLOBAL REAGENTS PROTEOMICS MARKET, BY REAGENTS TYPE, 2023-2035 ($MILLION)
  • TABLE 04. PROTEOMICS MARKET FOR INSTRUMENTS, BY REGION, 2023-2035 ($MILLION)
  • TABLE 05. GLOBAL INSTRUMENTS PROTEOMICS MARKET, BY INSTRUMENTS TYPE, 2023-2035 ($MILLION)
  • TABLE 06. PROTEOMICS MARKET FOR SERVICES, BY REGION, 2023-2035 ($MILLION)
  • TABLE 07. GLOBAL PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 08. PROTEOMICS MARKET FOR DRUG DISCOVERY, BY REGION, 2023-2035 ($MILLION)
  • TABLE 09. PROTEOMICS MARKET FOR DISEASE DIAGNOSIS, BY REGION, 2023-2035 ($MILLION)
  • TABLE 10. PROTEOMICS MARKET FOR OTHERS, BY REGION, 2023-2035 ($MILLION)
  • TABLE 11. PROTEOMICS MARKET, BY REGION, 2023-2035 ($MILLION)
  • TABLE 12. NORTH AMERICA PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 13. NORTH AMERICA PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 14. NORTH AMERICA PROTEOMICS MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 15. U.S. PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 16. U.S. PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 17. CANADA PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 18. CANADA PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 19. MEXICO PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 20. MEXICO PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 21. EUROPE PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 22. EUROPE PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 23. EUROPE PROTEOMICS MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 24. GERMANY PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 25. GERMANY PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 26. FRANCE PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 27. FRANCE PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 28. UK PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 29. UK PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 30. ITALY PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 31. ITALY PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 32. SPAIN PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 33. SPAIN PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 34. REST OF EUROPE PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 35. REST OF EUROPE PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 36. ASIA-PACIFIC PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 37. ASIA-PACIFIC PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 38. ASIA-PACIFIC PROTEOMICS MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 39. JAPAN PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 40. JAPAN PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 41. CHINA PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 42. CHINA PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 43. INDIA PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 44. INDIA PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 45. AUSTRALIA PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 46. AUSTRALIA PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 47. SOUTH KOREA PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 48. SOUTH KOREA PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 49. REST OF ASIA-PACIFIC PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 50. REST OF ASIA-PACIFIC PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 51. LAMEA PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 52. LAMEA PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 53. LAMEA PROTEOMICS MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 54. BRAZIL PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 55. BRAZIL PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 56. SAUDI ARABIA PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 57. SAUDI ARABIA PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 58. SOUTH AFRICA PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 59. SOUTH AFRICA PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 60. REST OF LAMEA PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 61. REST OF LAMEA PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 62. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
  • TABLE 63. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 64. THERMO FISHER SCIENTIFIC INC.: PRODUCT SEGMENTS
  • TABLE 65. THERMO FISHER SCIENTIFIC INC.: SERVICE SEGMENTS
  • TABLE 66. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
  • TABLE 67. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIES
  • TABLE 68. MERCK KGAA: KEY EXECUTIVES
  • TABLE 69. MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 70. MERCK KGAA: PRODUCT SEGMENTS
  • TABLE 71. MERCK KGAA: SERVICE SEGMENTS
  • TABLE 72. MERCK KGAA: PRODUCT PORTFOLIO
  • TABLE 73. MERCK KGAA: KEY STRATEGIES
  • TABLE 74. WATERS CORPORATION: KEY EXECUTIVES
  • TABLE 75. WATERS CORPORATION: COMPANY SNAPSHOT
  • TABLE 76. WATERS CORPORATION: PRODUCT SEGMENTS
  • TABLE 77. WATERS CORPORATION: SERVICE SEGMENTS
  • TABLE 78. WATERS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 79. WATERS CORPORATION: KEY STRATEGIES
  • TABLE 80. BIO-RAD LABORATORIES INC: KEY EXECUTIVES
  • TABLE 81. BIO-RAD LABORATORIES INC: COMPANY SNAPSHOT
  • TABLE 82. BIO-RAD LABORATORIES INC: PRODUCT SEGMENTS
  • TABLE 83. BIO-RAD LABORATORIES INC: SERVICE SEGMENTS
  • TABLE 84. BIO-RAD LABORATORIES INC: PRODUCT PORTFOLIO
  • TABLE 85. BIO-RAD LABORATORIES INC: KEY STRATEGIES
  • TABLE 86. AGILENT TECHNOLOGIES INC.: KEY EXECUTIVES
  • TABLE 87. AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT
  • TABLE 88. AGILENT TECHNOLOGIES INC.: PRODUCT SEGMENTS
  • TABLE 89. AGILENT TECHNOLOGIES INC.: SERVICE SEGMENTS
  • TABLE 90. AGILENT TECHNOLOGIES INC.: PRODUCT PORTFOLIO
  • TABLE 91. AGILENT TECHNOLOGIES INC.: KEY STRATEGIES
  • TABLE 92. LI-COR INC: KEY EXECUTIVES
  • TABLE 93. LI-COR INC: COMPANY SNAPSHOT
  • TABLE 94. LI-COR INC: PRODUCT SEGMENTS
  • TABLE 95. LI-COR INC: SERVICE SEGMENTS
  • TABLE 96. LI-COR INC: PRODUCT PORTFOLIO
  • TABLE 97. LI-COR INC: KEY STRATEGIES
  • TABLE 98. BRUKER CORPORATION: KEY EXECUTIVES
  • TABLE 99. BRUKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 100. BRUKER CORPORATION: PRODUCT SEGMENTS
  • TABLE 101. BRUKER CORPORATION: SERVICE SEGMENTS
  • TABLE 102. BRUKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 103. BRUKER CORPORATION: KEY STRATEGIES
  • TABLE 104. PERKIN ELMER INC: KEY EXECUTIVES
  • TABLE 105. PERKIN ELMER INC: COMPANY SNAPSHOT
  • TABLE 106. PERKIN ELMER INC: PRODUCT SEGMENTS
  • TABLE 107. PERKIN ELMER INC: SERVICE SEGMENTS
  • TABLE 108. PERKIN ELMER INC: PRODUCT PORTFOLIO
  • TABLE 109. PERKIN ELMER INC: KEY STRATEGIES
  • TABLE 110. DANAHER CORPORATION: KEY EXECUTIVES
  • TABLE 111. DANAHER CORPORATION: COMPANY SNAPSHOT
  • TABLE 112. DANAHER CORPORATION: PRODUCT SEGMENTS
  • TABLE 113. DANAHER CORPORATION: SERVICE SEGMENTS
  • TABLE 114. DANAHER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 115. DANAHER CORPORATION: KEY STRATEGIES
  • TABLE 116. HORIBA LTD.: KEY EXECUTIVES
  • TABLE 117. HORIBA LTD.: COMPANY SNAPSHOT
  • TABLE 118. HORIBA LTD.: PRODUCT SEGMENTS
  • TABLE 119. HORIBA LTD.: SERVICE SEGMENTS
  • TABLE 120. HORIBA LTD.: PRODUCT PORTFOLIO
  • TABLE 121. HORIBA LTD.: KEY STRATEGIES

LIST OF FIGURES

  • FIGURE 01. PROTEOMICS MARKET, 2023-2035
  • FIGURE 02. SEGMENTATION OF PROTEOMICS MARKET,2023-2035
  • FIGURE 03. TOP IMPACTING FACTORS IN PROTEOMICS MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN PROTEOMICS MARKET (2024-2035)
  • FIGURE 05. BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. BARGAINING POWER OF BUYERS
  • FIGURE 07. THREAT OF SUBSTITUTION
  • FIGURE 08. THREAT OF SUBSTITUTION
  • FIGURE 09. COMPETITIVE RIVALRY
  • FIGURE 10. GLOBAL PROTEOMICS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. PROTEOMICS MARKET, BY COMPONENT, 2023 AND 2035(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PROTEOMICS MARKET FOR REAGENTS, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF PROTEOMICS MARKET FOR INSTRUMENTS, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF PROTEOMICS MARKET FOR SERVICES, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 15. PROTEOMICS MARKET, BY APPLICATION, 2023 AND 2035(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF PROTEOMICS MARKET FOR DRUG DISCOVERY, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF PROTEOMICS MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF PROTEOMICS MARKET FOR OTHERS, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 19. PROTEOMICS MARKET BY REGION, 2023 AND 2035(%)
  • FIGURE 20. U.S. PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 21. CANADA PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 22. MEXICO PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 23. GERMANY PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 24. FRANCE PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 25. UK PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 26. ITALY PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 27. SPAIN PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 28. REST OF EUROPE PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 29. JAPAN PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 30. CHINA PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 31. INDIA PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 32. AUSTRALIA PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 33. SOUTH KOREA PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 34. REST OF ASIA-PACIFIC PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 35. BRAZIL PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 36. SAUDI ARABIA PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 37. SOUTH AFRICA PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 38. REST OF LAMEA PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 39. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 42. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 43. COMPETITIVE DASHBOARD
  • FIGURE 44. COMPETITIVE HEATMAP: PROTEOMICS MARKET
  • FIGURE 45. TOP PLAYER POSITIONING, 2023